204 related articles for article (PubMed ID: 6601984)
1. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V
Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984
[TBL] [Abstract][Full Text] [Related]
2. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
3. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.
Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z
Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623
[TBL] [Abstract][Full Text] [Related]
5. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
6. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix.
Savion N; Vlodavsky I; Fuks Z
J Cell Physiol; 1984 Feb; 118(2):169-78. PubMed ID: 6607256
[TBL] [Abstract][Full Text] [Related]
7. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
9. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V
Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426
[TBL] [Abstract][Full Text] [Related]
10. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
11. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
[TBL] [Abstract][Full Text] [Related]
12. Solubilization and degradation of extracellular matrix by various metastatic cell lines derived from a rat rhabdomyosarcoma.
Becker M; Moczar M; Poupon MF; Moczar E
J Natl Cancer Inst; 1986 Aug; 77(2):417-24. PubMed ID: 3461203
[TBL] [Abstract][Full Text] [Related]
13. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines.
Altevogt P; Fogel M; Cheingsong-Popov R; Dennis J; Robinson P; Schirrmacher V
Cancer Res; 1983 Nov; 43(11):5138-44. PubMed ID: 6616451
[TBL] [Abstract][Full Text] [Related]
14. Coordinate secretion and functional synergism of T cell-associated serine proteinase-1 (MTSP-1) and endoglycosidase(s) of activated T cells.
Vettel U; Bar-Shavit R; Simon MM; Brunner G; Vlodavsky I; Kramer MD
Eur J Immunol; 1991 Sep; 21(9):2247-51. PubMed ID: 1889464
[TBL] [Abstract][Full Text] [Related]
15. Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells.
Murayama K; Levery SB; Schirrmacher V; Hakomori S
Cancer Res; 1986 Mar; 46(3):1395-402. PubMed ID: 3484680
[TBL] [Abstract][Full Text] [Related]
16. Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line.
Schwartz-Albiez R; Steffen I; Lison A; Güttler N; Schirrmacher V; Keller R
Br J Cancer; 1988 Jun; 57(6):569-75. PubMed ID: 3408644
[TBL] [Abstract][Full Text] [Related]
17. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
Keren Z; Leland F; Nakajima M; LeGrue SJ
Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
[TBL] [Abstract][Full Text] [Related]
19. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
20. Production of sulfated proteoglycans by human breast cancer cell lines: binding to fibroblast growth factor-2.
Delehedde M; Deudon E; Boilly B; Hondermarck H
J Cell Biochem; 1997 Mar; 64(4):605-17. PubMed ID: 9093910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
